Breaking the mold: Overcoming resistance to immune checkpoint inhibitors

被引：3
|
作者：
Zhao, Menglu [1 ]
Yan, Chun-Yan [1 ]
Wei, Ya-Nan [1 ]
Zhao, Xi-He [1 ]
机构：
[1] China Med Univ, Shengjing Hosp, Dept Clin Oncol, Shenyang 110022, Peoples R China
来源：
ANTIVIRAL RESEARCH | 2023年 / 219卷
基金：
中国国家自然科学基金;
关键词：
PD-L1; Drug resistance; Bispecific antibody; Antibody drug conjugate (ADC); TUMOR MUTATIONAL BURDEN; T-CELLS; ANTITUMOR IMMUNITY; CANCER; IMMUNOTHERAPY; BLOCKADE; EFFICACY; RECEPTOR; PD-L1; EXPRESSION;
D O I：
10.1016/j.antiviral.2023.105720
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Immune checkpoint blockade-based therapies are effective against a sorts of cancers. However, drug resistance is a problem that cannot be ignored. This review intends to elucidate the mechanisms underlying drug tolerance induced by PD-1/PD-L1 inhibitors, as well as to outline proposed mechanism-based combination therapies and small molecule drugs that target intrinsic immunity and immune checkpoints. According to the differences of patients and types of cancer, the optimization of individualized combination therapy will help to enhance PD-1/ PD-L1-mediated immunoregulation, reduce chemotherapy resistance, and provide new ideas for chemotherapyresistant cancer.
引用
收藏
页数：11
相关论文
共 50 条
  • [1] Overcoming the resistance of pancreatic cancer to immune checkpoint inhibitors
    Skelton, Richard A.
    Javed, Ammar
    Zheng, Lei
    He, Jin
    JOURNAL OF SURGICAL ONCOLOGY, 2017, 116 (01) : 55 - 62
  • [2] Combining JAK Inhibitors with Immune Checkpoint Inhibitors: Overcoming Resistance in Cancer Treatment
    Zhong, Hai-Jing
    MEDCOMM, 2025, 6 (03):
  • [3] Overcoming resistance to immune checkpoint inhibitors in hepatocellular carcinoma: Challenges and opportunities
    Xie, Qingqing
    Zhang, Pengfei
    Wang, Yuanyuan
    Mei, Wuxuan
    Zeng, Changchun
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [4] Biological mechanisms of resistance to immune checkpoint inhibitors and overcoming this resistance: Challenges in medical oncology
    Moskalenko, Y.
    REGULATORY MECHANISMS IN BIOSYSTEMS, 2024, 15 (01) : 83 - 91
  • [5] Overcoming Resistance to Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinomas
    dos Santos, Lucas, V
    Abrahao, Carina M.
    William, William N.
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [6] Overcoming Resistance Mechanisms to Immune Checkpoint Inhibitors: Leveraging the Anti-Tumor Immune Response
    Coschi, Courtney H.
    Juergens, Rosalyn A.
    CURRENT ONCOLOGY, 2024, 31 (01) : 1 - 23
  • [7] Combination of immune checkpoint inhibitors with radiation therapy in cancer: A hammer breaking the wall of resistance
    Voronova, Veronika
    Vislobokova, Anastasia
    Mutig, Kerim
    Samsonov, Mikhail
    Peskov, Kirill
    Sekacheva, Marina
    Materenchuk, Maria
    Bunyatyan, Natalya
    Lebedeva, Svetlana
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [8] Acquired Resistance to Immune Checkpoint Inhibitors
    Schoenfeld, Adam J.
    Hellmann, Matthew D.
    CANCER CELL, 2020, 37 (04) : 443 - 455
  • [9] Mechanism of resistance to immune checkpoint inhibitors
    Pandey, Manu R.
    Ernstoff, Marc S.
    CANCER DRUG RESISTANCE, 2019, 2 (02) : 178 - 188
  • [10] Mechanisms of resistance to immune checkpoint inhibitors
    Russell W Jenkins
    David A Barbie
    Keith T Flaherty
    British Journal of Cancer, 2018, 118 : 9 - 16
12345